((1S)-3-Methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)carbamic acid 1,1-dimethylethyl ester

Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.


Product Name:                  ((1S)-3-Methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)carbamic acid 1,1-dimethylethyl ester

Synonyms:                         N/A

CAS Number:                     247068-82-2

Molecular Weight:            271.3558

Molecular Formula:          C14H25NO4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CC(C[C@@H](C(=O)[C@@]1(C)CO1)NC(=O)OC(C)(C)C)C

((1S)-3-Methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)carbamic acid 1,1-dimethylethyl ester

  • $415.00
  • Ex Tax: $415.00

Available Options